Sun H. Kim, MD, MS, Assistant Professor, Department of Medicine, Division of Endocrinology, Gerontology, and Metabolism, Stanford University School of Medicine
Research Description: Dr. Kim has been conducting patient-oriented research for over 10 years. Her research program has focused on mediators of type 2 diabetes development. She has led studies investigating the epidemiology and pathophysiology of prediabetes with a focus on insulin action and pancreatic beta-cell function. Recently, she has contributed new insights highlighting the role of insulin clearance in controlling glucose homeostasis. Dr. Kim is a co-leader of the Metabolism and Signaling in Diabetes Research Affinity Group in the Stanford DRC.
Selected relevant publications (Stanford DRC members in BOLD):
1. Kim SH, Abbasi F, Lamendola C, Liu A, Ariel D, Schaaf P, Grove K, Tomasso V, Ochoa H, Liu Y, Chen Y-I, Reaven G. 2013. Benefits of Liraglutide Treatment in Overweight/Obese, Older Individuals with Prediabetes. Diabetes Care 36:3276-82.
2. Kim SH, Liu A, Ariel D, Abbasi F, Lamendola C, Grove K, Tomasso K., Reaven G. 2013. Pancreatic Beta Cell Function following Liraglutide-augmented Weight Loss in Individuals with Prediabetes: analysis of a randomised, placebo-controlled study. Diabetalogia 57:455-62.
3. Kim SH, Liu A, Ariel D, Abbasi F, Lamendola C, Grove K, Tomasso V, Ochoa H, Reaven G. 2014. Effect of Salsalate on Insulin Action, Secretion, and Clearance in Nondiabetic, Insulin-Resistant Individuals: A Randomized, Placebo-Controlled Study. Diabetes Care 37:1944-50.
4. Kim SH, Silvers A, Viren J, Reaven G. 2016. Relationship between insulin sensitivity and insulin secretion rate: Not necessarily hyperbolic. Diabetic Medicine 33:961-7.
5. Kim MK, Reaven G, Kim SH. 2017. Dissecting the Relationship between Obesity and Hyperinsulinemia: Role of insulin secretion and insulin clearance. Obesity 25(2):378-383.